Journal of Medical Science Review

Biography

Dr. Hideyuki Takizawa is a physician-scientist with extensive experience in clinical medicine, biomedical research, and translational science. He currently serves as the Chief Medical Officer and Chief Research Officer at Cliffhanger Inc., Tokyo, where he leads the Division of Clinical Operations and Clinical Research Development, collaborating with leading global pharmaceutical companies including Pfizer, AstraZeneca, Merck & Co., and Roche.

Dr. Takizawa earned his MD and MSc from the Graduate School of Medicine, The University of Tokyo, Japan, and completed his Ph.D. in Internal Medicine with honors for excellence in scientific research and translational medicine. His multidisciplinary work integrates internal medicine, clinical laboratory medicine, and lipidomics, focusing on lipid metabolism and its role in metabolic and cardiovascular diseases, especially diabetes mellitus.

He has made significant contributions to understanding the biochemical and clinical mechanisms underlying metabolic disorders, particularly through his research on serum sphingolipids and glycerophospholipids. His studies have advanced the application of omics-based precision medicine and contributed to developing early diagnostic and therapeutic strategies for metabolic diseases.

Dr. Takizawa has authored several peer-reviewed publications and scientific presentations and continues to lead research initiatives that bridge fundamental biochemistry with clinical outcomes, promoting preventive and personalized medicine.

Research Interest

• Internal Medicine & Clinical Laboratory Medicine
• Lipid Metabolism and Metabolic Disorders
• Diabetes Mellitus and Cardiovascular Diseases
• Omics-Based Precision and Translational Medicine
• Biomarker Discovery and Disease Mechanisms
• Clinical Research Operations and Global Collaboration